KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q4 2019 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q4 2019 Earnings Conference Call
February 12, 2020 08:00 AM ET
Company Participants
Niranjan Kameswaran - Senior Vice President, Strategy
Mary Reumuth - Chief Financial Officer
Mark Iwicki - Chairman, President & Chief Executive Officer
Kim Brazzell - Chief Medical Officer
Todd Bazemore - Chief Operating Officer
Conference Call Participants
Liana Moussatos - Wedbush Securities
Chris Neyor - J.P. Morgan
Esther Rajavelu - Oppenheimer & Co.
Biren Amin - Jefferies LLC
Yi Chen - H.C. Wainwright & Co.
Presentation
*
Operator
Good morning and welcome to the Kala Pharmaceuticals' Fourth Quarter